Standout Papers

Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children 2007 2026 2013 2019 606
  1. Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children (2007)
    Robert B. Belshe, Kathryn M. Edwards et al. New England Journal of Medicine

Immediate Impact

5 by Nobel laureates 9 from Science/Nature 60 standout
Sub-graph 1 of 21

Citing Papers

Engineered commensals for targeted nose-to-brain drug delivery
2025 Standout
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
2023 Standout
8 intermediate papers

Works of Micki Hultquist being referenced

Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial
2009
SAFETY AND ANTIVIRAL ACTIVITY OF MOTAVIZUMAB, A RESPIRATORY SYNCYTIAL VIRUS (RSV)–SPECIFIC HUMANIZED MONOCLONAL ANTIBODY, WHEN ADMINISTERED TO RSV-INFECTED CHILDREN
2009
and 1 more

Author Peers

Author Last Decade Papers Cites
Micki Hultquist 855 356 292 13 1.2k
Thomas C. Shope 774 299 410 33 1.4k
Anna Mitus 377 167 159 28 1.4k
H Chapel 284 602 110 27 1.2k
Kim Knudsen 596 488 175 43 1.6k
Victoria Romanus 812 314 927 33 1.6k
Clare A. Dykewicz 794 116 439 22 1.6k
F. Eun‐Hyung Lee 292 525 304 39 1.3k
Greet J. Boland 853 375 234 63 1.5k
Stanley Usen 708 200 139 15 1.2k
Frederick Wittke 572 567 197 32 1.6k

All Works

Loading papers...

Rankless by CCL
2026